MY143200A - Monocyclic heterocycles as kinase inhibitors - Google Patents

Monocyclic heterocycles as kinase inhibitors

Info

Publication number
MY143200A
MY143200A MYPI20051789A MYPI20051789A MY143200A MY 143200 A MY143200 A MY 143200A MY PI20051789 A MYPI20051789 A MY PI20051789A MY PI20051789 A MYPI20051789 A MY PI20051789A MY 143200 A MY143200 A MY 143200A
Authority
MY
Malaysia
Prior art keywords
kinase inhibitors
monocyclic heterocycles
heterocycles
monocyclic
cancer
Prior art date
Application number
MYPI20051789A
Inventor
Robert M Borzilleri
Lyndon A M Cornelius
Robert J Schmidt
Gretchen M Schroeder
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MY143200A publication Critical patent/MY143200A/en

Links

Abstract

THE PRESENT INVENTION IS DIRECTED TO COMPOUNDS HAVING THE FORMULA Ι,ΙΙ, AND METHODS FOR USING THEM FOR THE TREATMENT OF CANCER.
MYPI20051789A 2004-04-23 2005-04-22 Monocyclic heterocycles as kinase inhibitors MY143200A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56484204P 2004-04-23 2004-04-23
US63917804P 2004-12-23 2004-12-23

Publications (1)

Publication Number Publication Date
MY143200A true MY143200A (en) 2011-03-31

Family

ID=37311769

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20051789A MY143200A (en) 2004-04-23 2005-04-22 Monocyclic heterocycles as kinase inhibitors

Country Status (5)

Country Link
AR (1) AR050410A1 (en)
MY (1) MY143200A (en)
PE (1) PE20060339A1 (en)
RU (1) RU2350603C2 (en)
TW (1) TWI324926B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012133416A1 (en) * 2011-03-29 2012-10-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 Method for producing phenoxypyridine derivative
TW201733984A (en) * 2011-04-13 2017-10-01 雅酶股份有限公司 Substituted benzene compounds

Also Published As

Publication number Publication date
RU2006141096A (en) 2009-01-20
TW200602023A (en) 2006-01-16
AR050410A1 (en) 2006-10-25
PE20060339A1 (en) 2006-04-21
RU2350603C2 (en) 2009-03-27
TWI324926B (en) 2010-05-21

Similar Documents

Publication Publication Date Title
HK1093159A1 (en) Monocyclic heterocycles as kinase inhibitors
UA85087C2 (en) Monocyclic heterocycles as kinase inhibitors
MX2007011545A (en) Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors.
EA200970486A1 (en) COMPOUNDS FOR INHIBITION OF MYTOZE
EA200970738A1 (en) AKT ACTIVITY INHIBITORS
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
EA201000093A1 (en) PYRIDAZINON DERIVATIVES
ATE554087T1 (en) NEW KINASE INHIBITORS
PT1940839E (en) Pyridopyrimidinone inhibitors of pi3kalpha
EA200970935A1 (en) TREATMENT METHODS WITH THE APPLICATION OF PI3K-ALPHA HYNAXOLINE INHIBITORS
TW200801008A (en) Protein kinase inhibitors
EA201100334A1 (en) BICYCLIC DERIVATIVES OF TRIAZOLE FOR THE TREATMENT OF TUMORS
WO2006123113A3 (en) Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
EA200870415A1 (en) QUINAZOLINS TO INHIBIT PDK 1
EA201070618A1 (en) 4-PYRAZOLYL-N-Arylpyrimidine-2-amines and 4-pyrazoyl-N-heteroarylpyrimidine-2-amines as an Inhibitor of Kinase JANUS
HK1131608A1 (en) Pyridinone compounds
EA201390085A1 (en) COMPOSITIONS OF KINAZ INHIBITORS FOR CANCER TREATMENT
UA101478C2 (en) Compounds useful as inhibitors of raf protein kinase
EA200901601A1 (en) PYRIDAZINON DERIVATIVES
SI1761520T1 (en) Kinase inhibitors
EA201100966A1 (en) PYRIDAZINON DERIVATIVES
EA200800374A1 (en) 1,4-DIHYDROPYRIDIN-CONDENSED HETEROCYCLES, METHODS FOR THEIR PRODUCTION, USE AND CONTAINING COMPOSITIONS
EA201001648A1 (en) PYRIDAZINON DERIVATIVES
EA200970936A1 (en) PYRIDO [2,3-d] PYRIMIDIN-7-IT COMPOUNDS AS PI3K-ALPHA INHIBITORS FOR CANCER TREATMENT
MX2010003563A (en) C-met protein kinase inhibitors.